Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion

Journal of Clinical Investigation

Volumn 113, Issue 5, 2004, Pages 737-745

  Sevilla, Noemí ^a,b   McGavern, Dorian B ^a   Teng, Chao ^a   Kunz, Stefan ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CD8 ANTIGEN; CD8ALPHA ANTIGEN; FLT3 LIGAND PROTEIN; GLYCOPROTEIN P 15095; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL DIVISION; CONFOCAL MICROSCOPY; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; SPLEEN; TIME; VIROLOGY;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD8; BONE MARROW CELLS; CELL DIVISION; DENDRITIC CELLS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

EID: 85047692244     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20243     Document Type: Article

References (69)

1. Bancahereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
2. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
3. Knight, S.C., and Patterson, S. 1997. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu. Rev. Immunol. 15:593-615.
4. Fugier-Vivier, I., et al. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:813-823.
5. Grosjean, I., et al. 1997. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med 186:801-812.
6. Schnorr, J.J., et al. 1997. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 94:5326-5331.
7. Andrews, D.M., Andoniou, C.E., Granucci, F., Ricciardi-Castagnoli, P., and Degli-Esposti, M.A. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:1077-1084.
8. Moutaftsi, M., Mehl, A.M., Borysiewicz, L.K., and Tabi, Z. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99:2913-2921.
9. Raftery, M.J., et al. 2001. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered vital defense strategy. Immunity. 15:997-1009.
10. Kruse, M., et al. 2000. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74:7127-7136.
11. Ho, L.J., et al. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166:1499-1506.
12. Wu, S.J., et al. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.
13. Borrow, P., et al. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
14. von Herrath, M.G., Guerder, S., Lewicki, H., Flavell, R.A., and Oldstone, M.B. 1995. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity. 3:727-738.
15. Zinkernagel, R.M., and Doherty, P.C. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51-177.
16. Pircher, H., Burki, K., Lang, R., Hengartner, H., and Zinkernagel, R.M. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342:559-561.
17. Ahmed, R., and Oldstone, M.B.A. 1988. Organ specific selection of viral variants during chronic infection. J. Exp. Med. 167:1719-1724.
18. Ahmed, R., Salmi, A., Butler, LD., Chiller, J.M., and Oldstone, M.B.A. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540.
19. Dockter, J., Evans, C.F., Tishon, A., and Oldstone, M.B. 1996. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J. Virol. 70:1799-1803.
20. Evans, C.F., Borrow, P., de la Torre, J.C., and Oldstone, M.B. 1994. Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J. Virol. 68:7367-7373.
21. Sevilla, N., et al. 2000. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192:1249-1260.
22. Ahmed, R., et al. 1991. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65:4242-4247.
23. Matloubian, M., Kolhekar, S.R., Somasundarum, T., and Ahmed, R. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67:7340-7349.
24. Villarete, L., Somasundaram, T., and Ahmed, R. 1994. Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells. J. Virol. 68:7490-7496.
25. Fung-Leung, W.P., Kundig, T.M., Zinkernagel, R.M., and Mak, T.W. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-1429.
26. Kagi, D., et al. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:528-530.
27. Tishon, A., Lewicki, H., Rall, G., Von Herrath, M., and Oldstone, M.B. 1995. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology. 212:244-250.
28. Borrow, P., Evans, C.F., and Oldstone, M.B.A. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immunosuppression. J. Virol. 69:1059-1070.
29. Salvato, M., Shimomaye, E., Southern, P., and Oldstone, M.B. 1988. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). Virology. 164:517-522.
30. Tishon, A., Borrow, P., Evans, C., and Oldstone, M.B. 1993. Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect. Virology. 195:397-405.
31. Althage, A., et al. 1992. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur. J. Immunol. 22:1803-1812.
32. Borrow, P., Tishon, A., and Oldstone, M.B.A. 1991. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection. J. Exp. Med. 174:203-212.
33. Odermatt, B., Eppler, M., Leist, T.P., Hengatner, H., and Zinkernagel, R.M. 1991. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. U. S. A. 88:8252-8256.
34. Smelt, S.C., et al. 2001. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 75:448-457.
35. Dutko, FJ., and Oldstone, M.B. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
36. Muller, U., et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921.
37. Lutz, M.B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.
38. Maraskovsky, E., et al. 1997. Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice. Adv. Exp. Med. Biol. 417:33-40.
39. Shaw, S.G., Maung, A.A., Steptoe, R.J., Thomson, A.W., and Vujanovic, N.L. 1998. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161:2817-2824.
40. Winzler, C., et al. 1997. Maturation stages of mouse dendritic cells in growth Factor-dependent long-term cultures. J. Exp. Med. 185:317-328.
41. Pierre, P., et al. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 388:787-792.
42. Cella, M., Engering, A., Pinet, V., Pieters, J., and Lanzavecchia, A. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:782-787.
43. Dalod, M., et al. 2002. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-528.
44. McNally, J.M., et al. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75:5965-5976.
45. Ou, R., Zhou, S., Huang, L., and Moskophidis, D. 2001. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75:8407-8423.
46. Lee, C.K., Gimeno, R., and Levy, D.E. 1999. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes. J. Exp. Med. 190:1451-1464.
47. Lee, C.K., Smith, E., Gimeno, R., Gertner, R., and Levy, D.E. 2000. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J. Immunol. 164:1286-1292.
48. Borrow, P., et al. 1996. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 183:2129-2142.
49. Griffin, D.E., et al. 1987. In vitro studies of the role of monocytes in the immunosuppression associated with natural measles virus infections. Clin. Immunol. Immunopathol. 45:375-383.
50. Hicks, J.T., Sullivan, J.L., and Albrecht, P. 1977. Immune responses during measles infection in immunosuppressed Rhesus monkeys. J. Immunol. 119:1452-1456.
51. McChesney, M.B., and Oldstone, M.B. 1989. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Adv. Immunol. 45:335-380.
52. Smithwick, E.M., and Berkovich, S. 1966. In vitro suppression of the lymphocyte response to tuberculin by live measles virus. Proc. Soc. Exp. Biol. Med. 123:276-278.
53. Schneider-Schaulies, S., Niewiesk, S., Schneider-Schaulies, J., and ter Meulen, V. 2001. Measles virus induced immunosuppression: targets and effector mechanisms. Curr. Mol. Med. 1:163-181.
54. Vidalain, P.O., Azocar, O., Rabourdin-Combe, C., and Servet-Delprat, C. 2001. Measle virus-infected dendritic cells develop immunosuppressive and cytotoxic activities. Immunobiology. 204:629-638.
55. Lyman, S.D., et al. 1993. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell. 75:1157-1167.
56. Lyman, S.D., and Jacobsen, S.E. 1998. c-kit ligand and Flt3 ligand stem/progenitor cell factors with overlapping yet distinct activities. Blood. 91:1101-1134.
57. Rasko, J.E., Metcalf, D., Rossner, M.T., Begley, C.G., and Nicola, N.A. 1995. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia. 9:2058-2066.
58. Oldstone, M.B. 1989. Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. J. Infect. Dis. 159:384-389.
59. Oldstone, M.B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263:83-117.
60. de la Torre, J.C., and Oldstone, M.B. 1996. Anatomy of viral persistence: mechanisms of persistence and associated disease. Adv. Virus Res. 46:311-343.
61. Levis, S.C., et al. 1985. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5:383-389.
62. Levis, S.C., et al. 1984. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 149:428-433.
63. Kurane, I., et al. 1993. High levels of interferon alpha in the sera of children with dengue virus infection. Am. J. Trop. Med. Hyg. 48:222-229.
64. McCormick, J.B., and Fisher-Hoch, S.P. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
65. Villinger, F., et al. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and rumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179(Suppl. 1):S188-S191.
66. Peters, J.H., Gieseler, R., Thiele, B., and Steinbach, F. 1996. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol. Today. 17:273-278.
67. Pierre, P., and Mellman, I. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93:1135-1145.
68. Stumptner-Cuvelette, P., et al. 2001. HIV-1 Nefimpairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad Sci. U. S. A. 98:12144-12149.
69. Cebulla, C.M., et al. 2002. Human cytomegalovirus disrupts constitutive MHC class II expression. J. Immunol. 169:167-176.